Academic Achievement
- Home
- About
- Academic Achievement
- 2023 Academic Publications
- CHLOE: The AI-Powered Embryo Scoring System That’s Revolutionizing Live Birth Outcomes in IVF
CHLOE: The AI-Powered Embryo Scoring System That’s Revolutionizing Live Birth Outcomes in IVF
Share
Presented by NUWA Fertility at the 2023 American Society for Reproductive Medicine (ASRM)
At the 2023 ASRM annual meeting, NUWA Fertility presented a groundbreaking study demonstrating the exceptional performance of the AI-powered embryo scoring system CHLOE in predicting live birth outcomes following day-5 single embryo transfers. This represents a major step forward in improving IVF success rates worldwide.
Background: Objective Embryo Assessment to Improve Live Birth Potential
In IVF treatment, selecting the embryo with the highest potential to result in a live birth is critical to success. Traditional embryo grading methods rely heavily on subjective morphological evaluations made by embryologists, which can vary between practitioners.
To improve accuracy and consistency, AI-based embryo evaluation systems have been developed. This study aimed to assess the effectiveness of the CHLOE scoring system in predicting live birth rates after single blastocyst transfers—and to compare its performance with that of the well-known KIDScore system.
CHLOE provides a more objective, standardized method for assessing embryo quality, improving accuracy and efficiency in embryo selection.
Results: Strong Positive Correlation Between CHLOE Scores and Live Birth Outcomes
The study revealed a significant positive correlation between CHLOE scores and live birth rates following day-5 single embryo transfers.
In other words, the higher the CHLOE score, the greater the likelihood that the embryo would successfully result in a healthy newborn.
Even more impressively, the data showed that CHLOE may outperform KIDScore in predicting pregnancy outcomes—suggesting that CHLOE may offer superior accuracy in identifying the most viable embryos.
Clinical Significance: CHLOE Leads the Way in Precision Embryo Selection
The study concludes that the AI-based CHLOE scoring system delivers more objective and standardized embryo evaluations, significantly enhancing both the accuracy and efficiency of embryo selection.
With CHLOE’s support, embryologists can more confidently identify the single embryo with the highest live birth potential, helping increase overall IVF success rates and bring more hopeful parents closer to their dream of having a healthy baby.
NUWA Fertility remains committed to adopting cutting-edge technologies that advance clinical outcomes in assisted reproduction.
By integrating the CHLOE AI embryo scoring system into clinical practice, we aim to further enhance our embryo selection strategies—delivering higher-quality, more efficient, and more personalized IVF care that drives higher live birth success rates.
Seminars